Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Gut. 2021 Apr 21;71(5):983–990. doi: 10.1136/gutjnl-2021-324264

Table.3.

Association between histological response and ≥ 30% relative decline in MRI-PDFF

Relative decline in MRI-PDFF ≥ 30% vs < 30% relative decline in MRI-PDFF

Histologic response (≥ 1 point/stage decrease) ≥ 30% (n = 25) < 30% (n = 75) Odds ratio 95%CI p value
Steatosis 64% 32% 3.78 1.5-9.8 0.006
Lobular inflammation 44% 24% 2.49 0.9-6.4 0.06
Ballooning 56% 41% 1.81 0.7-4.5 0.2
NAS response* 60% 24% 4.75 1.8-12 0.001
Fibrosis** 50% 21% 3.75 1.2-12 0.03
*

NAS response is defined as ≥ 2 points improvement in NAS with no worsening of fibrosis.

**

Fibrosis response limits to patients with fibrosis stage 1-4 at baseline.

MRI, magnetic resonance imaging; PDFF, proton density fat fraction; NAS, nonalcoholic fatty liver disease activity score; CI, confidence interval